Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study.

Makhlouf HA, Sadek SH, Nafady AAH.

Clin Respir J. 2018 Jan;12(1):48-56. doi: 10.1111/crj.12477. Epub 2016 May 3.

PMID:
27003100
2.

Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.

Malerba M, Olivini A, Radaeli A, Ricciardolo FL, Clini E.

Curr Med Res Opin. 2016 May;32(5):885-91. doi: 10.1185/03007995.2016.1149054. Epub 2016 Mar 2.

PMID:
26824631
3.

Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.

Wang RT, Li JY, Cao ZG, Li Y.

Respirology. 2013 Nov;18(8):1244-8. doi: 10.1111/resp.12143.

PMID:
23786593
4.

MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy.

Citirik M, Beyazyildiz E, Simsek M, Beyazyildiz O, Haznedaroglu IC.

Eye (Lond). 2015 Mar;29(3):376-9. doi: 10.1038/eye.2014.298. Epub 2014 Dec 19.

5.

The importance of laboratory parameters in patients with obstructive sleep apnea syndrome.

Kurt OK, Yildiz N.

Blood Coagul Fibrinolysis. 2013 Jun;24(4):371-4. doi: 10.1097/MBC.0b013e32835d53d4.

PMID:
23322273
6.

Relationship between the extent of dissection and platelet activation in acute aortic dissection.

Zhang S, Qian H, Yang Q, Hu J, Gan C, Meng W.

J Cardiothorac Surg. 2015 Nov 10;10:162. doi: 10.1186/s13019-015-0351-5.

7.

Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.

Biljak VR, Pancirov D, Cepelak I, Popović-Grle S, Stjepanović G, Grubišić TŽ.

Platelets. 2011;22(6):466-70. doi: 10.3109/09537104.2011.573887. Epub 2011 Apr 20.

PMID:
21506665
8.

Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities.

Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, Pita E, Maltezos E, Bouros D.

Angiology. 2013 Oct;64(7):535-9. doi: 10.1177/0003319712461436. Epub 2012 Oct 10.

PMID:
23052724
9.
10.

Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension.

Mese T, Guven B, Yilmazer MM, Karadeniz C, Ozdemir R, Doksoz O.

Congenit Heart Dis. 2018 Jul;13(4):506-511. doi: 10.1111/chd.12616. Epub 2018 Jul 17.

PMID:
30019380
11.

Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications.

Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, Singh S.

Hematology. 2011 Mar;16(2):86-9. doi: 10.1179/102453311X12902908412110.

PMID:
21418738
12.

Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease.

Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G.

Pol Arch Med Wewn. 2012;122(6):284-90. Epub 2012 May 11.

13.

Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension.

Zheng YG, Yang T, Xiong CM, He JG, Liu ZH, Gu Q, Zhao ZH, Ni XH.

Heart Lung Circ. 2015 Jun;24(6):566-72. doi: 10.1016/j.hlc.2014.11.025. Epub 2014 Dec 9.

PMID:
25573235
14.

[Change of platelet parameters in septic shock patients].

Gao Y, Li L, Li Y, Yu X, Sun T, Lan C.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jan;26(1):28-32. doi: 10.3760/cma.j.issn.2095-4352.2014.01.006. Chinese.

15.

Clinical value of mean platelet volume for impaired cardiopulmonary function in very old male patients with chronic obstructive pulmonary disease.

Cui H, Liu L, Wei Z, Wang D, Hu Y, Hu G, Fan L.

Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):e109-12. doi: 10.1016/j.archger.2011.09.013. Epub 2011 Oct 20.

PMID:
22018467
16.

Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients.

Jabeen F, Fawwad A, Rizvi HA, Alvi F.

Pak J Med Sci. 2013 Jan;29(1):152-6. doi: 10.12669/pjms.291.2592.

17.

Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.

Liu R, Gao F, Huo J, Yi Q.

Platelets. 2012;23(1):11-6. doi: 10.3109/09537104.2011.586073. Epub 2011 Jun 16.

PMID:
21675937
18.

Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.

Tang J, Gao X, Zhi M, Zhou HM, Zhang M, Chen HW, Yang QF, Liang ZZ.

J Dig Dis. 2015 Mar;16(3):118-24. doi: 10.1111/1751-2980.12225.

PMID:
25565427
19.

Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.

Taylan M, Demir M, Kaya H, Selimoglu Sen H, Abakay O, Carkanat Aİ, Abakay A, Tanrikulu AC, Sezgi C.

Clin Respir J. 2017 May;11(3):311-317. doi: 10.1111/crj.12336. Epub 2015 Aug 6.

PMID:
26096858
20.

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.

Duman D, Aksoy E, Agca MC, Kocak ND, Ozmen I, Akturk UA, Gungor S, Tepetam FM, Eroglu SA, Oztas S, Karakurt Z.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2469-78. doi: 10.2147/COPD.S90330. eCollection 2015. Erratum in: Int J Chron Obstruct Pulmon Dis. 2016;11:417.

Supplemental Content

Support Center